MRES (Institute of Biomedical Research) Total Inventories: $0.00 Mil (As of Dec. 2010)


What is Institute of Biomedical Research Total Inventories?

Institute of Biomedical Research MRES Total Inventories is $0.00 Mil as of Dec. 2010.

Institute of Biomedical Research's total inventories for the quarter that ended in Dec. 2010 was $0.00 Mil. Institute of Biomedical Research's average total inventories from the quarter that ended in Sep. 2010 to the quarter that ended in Dec. 2010 was $0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Institute of Biomedical Research's Net-Net Working Capital per share for the quarter that ended in Dec. 2010 was $-0.01.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Institute of Biomedical Research  (OTCPK:MRES) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Institute of Biomedical Research's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2010 is

Net-Net Working Capital Per Share (Q: Dec. 2010 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0+0.75 * 0+0.5 * 0-0.461
-0-0)/66.281
=-0.01

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Institute of Biomedical Research's Days Inventory for the three months ended in Dec. 2010 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2010 )/Cost of Goods Sold (Q: Dec. 2010 )*Days in Period
=0/0*365 / 4
=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Institute of Biomedical Research's Inventory Turnover for the quarter that ended in Dec. 2010 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2010 ) / Average Total Inventories (Q: Dec. 2010 )
=0 / 0
=N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Institute of Biomedical Research's Inventory to Revenue for the quarter that ended in Dec. 2010 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2010 ) / Revenue (Q: Dec. 2010 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Institute of Biomedical Research Total Inventories Related Terms

Institute of Biomedical Research Total Inventories Historical Data

* Premium members only.

The historical data trend for Institute of Biomedical Research's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Institute of Biomedical Research Total Inventories Chart

Institute of Biomedical Research Annual Data
Trend Dec03 Dec04 Mar06 Mar07 Mar08 Mar09 Mar10
Total Inventories
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Institute of Biomedical Research Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Institute of Biomedical Research Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of $0.00 Mil mean?
Institute of Biomedical Research (MRES) has a Total Inventories of $0.00 Mil as of Dec. 2010. The total amount of inventory as recorded on a company's balance sheet. View historical data for Institute of Biomedical Research and its competitors.
Is Institute of Biomedical Research's Total Inventories too high?
Institute of Biomedical Research's current Total Inventories is $0.00 Mil.
How does Institute of Biomedical Research's Total Inventories compare to HSTC and NTRR?
Institute of Biomedical Research's Total Inventories of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Institute of Biomedical Research and its competitors. Institute of Biomedical Research's current Total Inventories is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Institute of Biomedical Research stock overvalued right now?
Institute of Biomedical Research (MRES) has a current Total Inventories of $0.00 Mil. The current Total Inventories is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Institute of Biomedical Research (MRES), the current Total Inventories is $0.00 Mil as of Dec. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Institute of Biomedical Research Business Description

Address Dubai Science Park, 13th Floor, South Tower, Dubai, ARE, 416452
Institute of Biomedical Research Corp is a biomedical research and development company. The company is focused on alternative plant-based food and medicine and mental health therapeutic research. The company uses brand name M2Bio Sciences engaged in deploying artificial intelligence, science and medicine, clinical research, and emerging technologies.